Rapid Medical Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Rapid Medical Ltd. - overview

Established

2008

Location

Yokneam Illit, -, Israel

Primary Industry

Medical Devices & Equipment

About

Founded in 2008 and based in Yokneam, Israel, Rapid Medical Ltd. operates as a developer of neurovascular interventional devices. Ronen Eckhouse and Shimon Eckhouse are the co-founders of the company. In May 2021, the firm raised USD 50 million in Series D funding led by Microport Scientific Corporation including CPE Capital and Deep Insight Inc.


The company's products include Tigertriever, Tigertriever13, TigertrieverXL, which are adjustable clot retrievers for the treatment of ischemic stroke, and Comaneci, an adjustable remodeling mesh for the treatment of brain aneurysm, and also Columbus, a steerable guidewire. The organization is committed to advancing patient care by providing reliable, easy to use and high-quality products proven by clinical data. Rapid Medical plans to use the May 2021 funding to support the fast commercial growth of the company’s minimally invasive stroke products worldwide and to expand commercial operations in the US and Europe, and also for regulatory approvals in new strategic territories such as China.


Current Investors

BRM Group, Winnovation, Gefen Capital

Primary Industry

Medical Devices & Equipment

Sub Industries

Biotechnology, Medical Devices & Equipment

Website

www.rapid-medical.com

Company Stage

Series D

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.